149 Infos zu Torsten Mummenbrauer

38 Aktuelle Nachrichten

— Torsten Mummenbrauer prévoit le début des essais cliniques dès ... « Si on veut produire rapidement, on aura besoin du soutien des pouvoirs ...

— Torsten Mummenbrauer, CEO of ExeVir Bio, said: "We are very pleased to collaborate with Mithra which has built a cutting-edge new fill and ...

... Torsten Mummenbrauer Appointed SVP Business Development &. Licensing of Hookipa Biotech. Vienna, Austria, 11 October Hookipa Biotech AG, a ...

EnzyPep B. V. | torsten Mummenbrauer • Hookipa Biotech AG | Ron. Meyer • InflaRx AG | Dr. Daniel Müller • MyBiotech GmbH | Dr. Wolfgang. Söhngen • PAION AG.

6 Profile in Sozialen Netzwerken

StayFriends - Schulfreunde wiederfinden

Sehen Sie sich das Profil von Torsten Mummenbrauer im größten Business-Netzwerk der Welt an. Im Profil von Torsten Mummenbrauer sind 5 Jobs angegeben.

View Torsten Mummenbrauer's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Torsten ...

Torsten Mummenbrauer (ExeVir Bio B.V.). Mummenbrauer, Torsten (ExeVir Bio – CEO before Velvio Gmbh + Hookipa + MorphoSys + GSK Vaccines). Organisations ...

3 Hobbys & Interessen

— Torsten Mummenbrauer (GlaxoSmithKline), Dr. Thomas Baier (Roche Applied Science), Dr. Andreas Weith (Boehringer Ingelheim Pharma), Dr ...

Torsten Mummenbrauer, Friedemann Janus, Beate Müller, Lisa Wiesmüller, Wolfgang Deppert, Frank Grosse. Cell. Volume 85 Issue 7 Pages (June 1996). DOI ...

— Torsten Mummenbrauer, CEO of ExeVir Bio, said: "We are committed to the international effort against Covid-19 to support healthcare systems ...

6 Business-Profile

Torsten Mummenbrauer is the CEO at ExeVir Bio .

Torsten Mummenbrauer is currently Chief Executive Officer at ExeVir Bio. At ExeVir Bio, Torsten Mummenbrauer has 10 colleagues including Michel Kazatchkine ...

WebTorsten Mummenbrauer ist derzeit Chief Executive Officer at ExeVir Bio - View - ExeVir Bio org chart. Meldung erstellen um der Kariere von Torsten Mummenbrauer …

Torsten Mummenbrauer (ExeVir Bio B.V.). Mummenbrauer, Torsten (ExeVir Bio – CEO before Velvio Gmbh + Hookipa + MorphoSys + GSK Vaccines) ...

1 Firmen-Mitarbeiter

Dr. Torsten Mummenbrauer ... Experienced deal maker with proven track record in biotech financing (from seed to IPO) and 25 years of operational biotech and ...

3 Bücher zum Namen

... Torsten MUMMENBRAUER Garching Innovation Germany Mr. Doug NELSON CROPLIFE America United States Mr. Fabirama NIANG Université Louis Pasteur France Ms ...

Few topics in the life sciences today provoke as much debate as the availability of patent protection on

Front Cover. Torsten Mummenbrauer pages. 0 Reviewshttps://books.google.com/books/about/Identifikation_und_Charakterisierung_Der.html?id= ...

2 Dokumente

von KT Hohn · · Zitiert von: 48 — Torsten Mummenbrauer, Friedemann Janus, Beate Müller, Lisa Wiesmüller, Wolfgang Deppert, Frank Grosse. p53 Protein Exhibits 3′-to

“We plan to start commerical production in the first half of and start shipping the antiviral treatment by the end of ” Torsten Mummenbrauer, CEO of ...

6 Wissenschaftliche Publikationen

von T Mummenbrauer · · Zitiert von: 367 — p53 Protein Exhibits 3′-to-5′ Exonuclease Activity. Author links open overlay panel. Torsten Mummenbrauer 1 , Friedemann Janus 1 , Beate Müller 1 , Lisa ...

Negative feedback regulation of wild-type p53 biosynthesis. Jörn Mosner, Torsten Mummenbrauer, Christian Bauer, Georg Sczakiel, Frank Grosse, Wolfgang Deppert*.

— Torsten Mummenbrauer, PDG d'ExeVir Bio, se montre enthousiaste : « Nous sommes impatients de nous joindre à la lutte internationale contre ...

WebJörn Mosner, Torsten Mummenbrauer, Christian Bauer, Georg Sczakiel, Frank Grosse, Wolfgang Deppert * * Korrespondierende/r Autor/-in für diese Arbeit. Institut für …

2 Allgemeine Veröffentlichungen

von B Muller · · Zitiert von: 367 — Torsten Mummenbrauer,* Friedemann Janus,* age-induced p53 functions, evidence for a direct in- volvement of p53 in cellular DNA replication ...

— Torsten Mummenbrauer, CEO of ExeVir Bio, said: “We are very pleased to collaborate with. Mithra which has built a cutting-edge new fill and ...

2 Video- & Audioinhalte

Torsten Mummenbrauer, SVP, Business Development & Licensing at Hookipa Pharma Inc., collects the Lifestars Award for EU Deal of the ...

6 Meinungen & Artikel

Torsten Mummenbrauer, Senior VP Business Development & Licensing will present at Deutsche Biotechnologietage #DBT2018 in #Berlin ...

— Dr Torsten Mummenbrauer, CEO of ExeVir, said: “The ExeVir team has quickly developed significant expertise in leveraging its modular ...

— ... Torsten Mummenbrauer, Senior Vice President Business Development, Management, Hookipa Biotech GmbH; Wolfgang Brysch, Founder and Chief ...

— Torsten Mummenbrauer, CEO of ExeVir, said: “Our unique and powerful approach of targeting three highly conserved epitopes in the SARS-CoV

73 Webfunde aus dem Netz

— Torsten Mummenbrauer, CEO of ExeVir, said: “Whilst an end was declared to COVID-19 as a public health emergency by the WHO, the pandemic is ...

Dr Torsten Mummenbrauer appointed SVP Business Development & Licensing of Hookipa Biotech. Dr Mummenbrauer brings almost 20 years of business development ...

— Torsten Mummenbrauer, CEO of ExeVir, added, " The collaboration with Nona Biosciences will be an important support in our ongoing research ...

Dr. Torsten Mummenbrauer Appointed SVP Business Development & Licensing Of Hookipa Biotech - read this article along with other careers information, ...

Torsten Mummenbrauer. Home; Dr. Torsten Mummenbrauer. European Investment Bank Provides $26.7MM Venture Debt Financing to ExeVir Bio. ExeVir Bio, a biotech ...

Torsten Mummenbrauer. CEO at ExeVir. Contact. Torsten is CEO of ExeVir Bio. He ... Peers. Torsten Mummenbrauer's profile picture. Torsten Mummenbrauer. CEO ...

Torsten Mummenbrauer's Summary. Torsten Mummenbrauer, based in Germany, is currently a Chief Executive Officer at Exevir Bio, bringing experience from previous ...

Dr. Torsten Mummenbrauer is Senior VP Business Development & Licensing at Hookipa. With almost 20 years of business development experience in the life ...

— Torsten Mummenbrauer connaît bien la Belgique, les vaccins et les pandémies. Le profil idéal pour piloter la biotech belge ExeVir dans la ...

Dr. Torsten Mummenbrauer · Chief Executive Officer ; Prof. Dr. med Ulrich Bogdahn · Chief Medical Officer ; Dr. Tim-Henrik Bruun · Chief Operating Officer.

— ExeVir is a spin-off of VIB and is headed by German Dr. Torsten Mummenbrauer, a virologist who has worked for GSK Morphosys, Hookipa Pharma ...

Torsten Mummenbrauer, CEO of ExeVir, said: “We're delighted with this support from the Flemish Government as it will help us with our research into using ...

Torsten Mummenbrauer, GlaxoSmithKline Biologicals Torsten Mummenbrauer, GlaxoSmithKline Biologicals,. Wavre, B. Udo Neuhäußer, Bundesministerium für ...

UCB and Fund+ are supporting a spin out from the renowned VIB research institute and ExeVir Bio CEO Torsten Mummenbrauer told Scrip that the firm's llama ...

— Dr. Torsten Mummenbrauer, CEO of ExeVir, said: “The ExeVir team has quickly developed expertise in leveraging its modular VHH platform to ...

ExeVir Bio. Last updated: October 22, Torsten Mummenbrauer, CEO. Country: Belgium | Funding: €68.6M (+) Website: https://exevir.com/

Mummenbrauer Direktor Stefaan Heylen GF Torsten Mummenbrauer Direktor Jeanne Bolger Direktor M. Kazatchkine Direktor J. van Biervliet. Netzwerk. Netzwerk wird ...

Chief executive Torsten Mummenbrauer said: “We have come so far since 2020, including securing $20 million in major grants, closing a $50 million Series A ...

Torsten Mummenbrauer, CEO of ExeVir, said “Whilst an end was declared to COVID-19 as a public health emergency by the WHO, the pandemic is still continuing ...

ExeVir Bio's Director is Erica Whittaker. Other executives include Torsten Mummenbrauer, Chief Executive Officer; Jérôme van Biervliet, Director and